Theranos, a Blood Test Start-Up, Faces F.D.A. Scrutiny

Friday, October 16, 2015 - 23:20 in Health & Medicine

In response to questions raised by the Food and Drug Administration, the medical testing start-up has temporarily stopped its signature practice of collecting tiny blood samples from finger pricks.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net